Overview

A Study of LY3316531 in Healthy Participants

Status:
Completed
Trial end date:
2019-03-15
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess study drug activity by giving LY3316531 or placebo into a vein in the arm and then measuring blood flow to the skin, after capsaicin is applied to skin's surface. The study will last about 16 weeks inclusive of the screening period.
Phase:
Phase 1
Details
Lead Sponsor:
Eli Lilly and Company